File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jcmgh.2023.01.007
- Scopus: eid_2-s2.0-85150355145
- WOS: WOS:000956649800001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
Title | Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells |
---|---|
Authors | |
Keywords | Hepatocellular Carcinoma Immune Milieu Interactions Liver Tumor Initiating Cells Tumor Microenvironment |
Issue Date | 1-Jan-2023 |
Publisher | Elsevier |
Citation | Cellular and Molecular Gastroenterology and Hepatology, 2023, v. 15, n. 5, p. 1105-1116 How to Cite? |
Abstract | Liver cancer (hepatocellular carcinoma) is a common cancer worldwide. It is an aggressive cancer, with high rates of tumor relapse and metastasis, high chemoresistance, and poor prognosis. Liver tumor-initiating cells (LTICs) are a distinctive subset of liver cancer cells with self-renewal and differentiation capacities that contribute to intratumoral heterogeneity, tumor recurrence, metastasis, and chemo-drug resistance. LTICs, marked by different TIC markers, have high plasticity and use diverse signaling pathways to promote tumorigenesis and tumor progression. LTICs are nurtured in the tumor microenvironment (TME), where noncellular and cellular components participate to build an immunosuppressive and tumor-promoting niche. As a result, the TME has emerged as a promising anticancer therapeutic target, as exemplified by some successful applications of tumor immunotherapy. In this review, we discuss the plasticity of LTICs in terms of cellular differentiation, epithelial–mesenchymal transition, and cellular metabolism. We also discuss the various components of the TME, including its noncellular and cellular components. Thereafter, we discuss the mutual interactions between TME and LTICs, including recently reported molecular mechanisms. Lastly, we summarize and describe new ideas concerning novel approaches and strategies for liver cancer therapy. |
Persistent Identifier | http://hdl.handle.net/10722/331715 |
ISSN | 2023 Impact Factor: 7.1 2023 SCImago Journal Rankings: 2.702 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huang, Hongyang | - |
dc.contributor.author | Tsui, Yu-Man | - |
dc.contributor.author | Ng, Irene Oi-Lin | - |
dc.date.accessioned | 2023-09-21T06:58:15Z | - |
dc.date.available | 2023-09-21T06:58:15Z | - |
dc.date.issued | 2023-01-01 | - |
dc.identifier.citation | Cellular and Molecular Gastroenterology and Hepatology, 2023, v. 15, n. 5, p. 1105-1116 | - |
dc.identifier.issn | 2352-345X | - |
dc.identifier.uri | http://hdl.handle.net/10722/331715 | - |
dc.description.abstract | <p> Liver cancer (hepatocellular carcinoma) is a common cancer worldwide. It is an aggressive cancer, with high rates of tumor relapse and metastasis, high chemoresistance, and poor prognosis. Liver tumor-initiating cells (LTICs) are a distinctive subset of liver cancer cells with self-renewal and differentiation capacities that contribute to intratumoral heterogeneity, tumor recurrence, metastasis, and chemo-drug resistance. LTICs, marked by different TIC markers, have high plasticity and use diverse signaling pathways to promote tumorigenesis and tumor progression. LTICs are nurtured in the tumor microenvironment (TME), where noncellular and cellular components participate to build an immunosuppressive and tumor-promoting niche. As a result, the TME has emerged as a promising anticancer therapeutic target, as exemplified by some successful applications of tumor immunotherapy. In this review, we discuss the plasticity of LTICs in terms of cellular differentiation, epithelial–mesenchymal transition, and cellular metabolism. We also discuss the various components of the TME, including its noncellular and cellular components. Thereafter, we discuss the mutual interactions between TME and LTICs, including recently reported molecular mechanisms. Lastly, we summarize and describe new ideas concerning novel approaches and strategies for liver cancer therapy. <br></p> | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation.ispartof | Cellular and Molecular Gastroenterology and Hepatology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Hepatocellular Carcinoma | - |
dc.subject | Immune Milieu | - |
dc.subject | Interactions | - |
dc.subject | Liver Tumor Initiating Cells | - |
dc.subject | Tumor Microenvironment | - |
dc.title | Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jcmgh.2023.01.007 | - |
dc.identifier.scopus | eid_2-s2.0-85150355145 | - |
dc.identifier.volume | 15 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 1105 | - |
dc.identifier.epage | 1116 | - |
dc.identifier.eissn | 2352-345X | - |
dc.identifier.isi | WOS:000956649800001 | - |
dc.identifier.issnl | 2352-345X | - |